As a generally held principle, mere investment or ownership interest in a company does not expose the investor to liability for acts undertaken by the company. However, that principle is being called into question in the context of private equity firms investing in healthcare companies. In two recent cases, healthcare companies along with their sole or majority private equity firm owners settled False Claims Act (“FCA”) cases. These cases illustrate the risk that private equity investors in the healthcare space may face under the FCA, particularly to the extent that they actively manage their portfolio companies.
Trending
- $3 Billion HealthTech Merger Aims to Cure Late Payments (PYMNTS)
- Podcast- Innovation: Dieta Health with Asaf Kraus (The Gut Doctor)
- AI-Based Patient Navigator Improves Colonoscopy Rates in Underserved Community (GI & Endoscopy News)
- A new blood test doesn’t change the game for colorectal cancer screening (Peter Attia)
- Will Generative AI replace Doctors? (Verge of Singularity)
- Qualified retirement plans offer pros and cons for practice owners and employees (Healio)
- The GI procedures eligible for UnitedHealthcare’s new gold card program (Becker’s GI & Endoscopy)
- Hoag Digestive Health Institute Welcomes Dr. Jennifer Phan as Medical Director of Hoag Irvine Advanced Endoscopy Center (PR Newswire)